| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Dysfunction, Left | 21 | 2022 | 435 | 4.770 |
Why?
|
| Echocardiography | 45 | 2023 | 1182 | 4.430 |
Why?
|
| Ventricular Function, Left | 22 | 2023 | 603 | 3.320 |
Why?
|
| Echocardiography, Doppler | 16 | 2020 | 180 | 2.590 |
Why?
|
| Heart Ventricles | 20 | 2023 | 846 | 2.540 |
Why?
|
| Stroke Volume | 18 | 2023 | 577 | 1.520 |
Why?
|
| Myocardial Contraction | 8 | 2019 | 291 | 1.470 |
Why?
|
| Isolated Noncompaction of the Ventricular Myocardium | 9 | 2023 | 44 | 1.450 |
Why?
|
| Hypoplastic Left Heart Syndrome | 5 | 2022 | 218 | 1.220 |
Why?
|
| Ventricular Function | 5 | 2016 | 93 | 1.170 |
Why?
|
| Anthracyclines | 3 | 2020 | 331 | 1.170 |
Why?
|
| Heart Diseases | 7 | 2023 | 732 | 1.150 |
Why?
|
| Heart Defects, Congenital | 14 | 2020 | 1697 | 1.100 |
Why?
|
| Antibiotics, Antineoplastic | 2 | 2020 | 726 | 0.990 |
Why?
|
| Heart Septal Defects, Atrial | 11 | 2023 | 125 | 0.960 |
Why?
|
| Atrial Function, Left | 2 | 2020 | 24 | 0.950 |
Why?
|
| Heart Atria | 5 | 2020 | 352 | 0.910 |
Why?
|
| Child | 69 | 2023 | 29154 | 0.900 |
Why?
|
| Cardiac Catheterization | 12 | 2023 | 687 | 0.770 |
Why?
|
| Anemia, Sickle Cell | 3 | 2020 | 339 | 0.760 |
Why?
|
| Heart | 8 | 2023 | 1223 | 0.730 |
Why?
|
| Cardiomyopathy, Dilated | 7 | 2016 | 244 | 0.700 |
Why?
|
| Predictive Value of Tests | 13 | 2023 | 4892 | 0.700 |
Why?
|
| Aortic Valve Stenosis | 5 | 2020 | 476 | 0.690 |
Why?
|
| Coronary Aneurysm | 1 | 2019 | 36 | 0.670 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2019 | 76 | 0.640 |
Why?
|
| Septal Occluder Device | 5 | 2023 | 49 | 0.620 |
Why?
|
| Pulmonary Valve | 2 | 2017 | 87 | 0.580 |
Why?
|
| Torsion Abnormality | 1 | 2016 | 38 | 0.580 |
Why?
|
| Cancer Survivors | 2 | 2020 | 650 | 0.570 |
Why?
|
| Infant | 36 | 2022 | 13310 | 0.550 |
Why?
|
| Child, Preschool | 44 | 2021 | 16273 | 0.520 |
Why?
|
| Cardiomyopathies | 5 | 2023 | 610 | 0.500 |
Why?
|
| Heart Transplantation | 4 | 2020 | 908 | 0.500 |
Why?
|
| Cardiology | 1 | 2020 | 530 | 0.500 |
Why?
|
| Adolescent | 44 | 2021 | 31252 | 0.490 |
Why?
|
| Ventricular Function, Right | 5 | 2022 | 111 | 0.490 |
Why?
|
| Ebstein Anomaly | 1 | 2014 | 20 | 0.480 |
Why?
|
| Cardiomyopathy, Hypertrophic | 4 | 2009 | 192 | 0.470 |
Why?
|
| Body Surface Area | 4 | 2021 | 42 | 0.460 |
Why?
|
| Humans | 103 | 2023 | 261506 | 0.450 |
Why?
|
| Echocardiography, Three-Dimensional | 2 | 2010 | 66 | 0.440 |
Why?
|
| Systole | 8 | 2022 | 196 | 0.430 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2023 | 136 | 0.430 |
Why?
|
| Electroencephalography | 1 | 2016 | 898 | 0.420 |
Why?
|
| Prospective Studies | 16 | 2022 | 12873 | 0.420 |
Why?
|
| Latin America | 2 | 2022 | 115 | 0.410 |
Why?
|
| Infant, Newborn | 22 | 2023 | 8223 | 0.400 |
Why?
|
| Female | 67 | 2022 | 141928 | 0.400 |
Why?
|
| Reproducibility of Results | 14 | 2022 | 6009 | 0.390 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2012 | 84 | 0.380 |
Why?
|
| Adrenalectomy | 1 | 2012 | 188 | 0.380 |
Why?
|
| Neoplasms | 7 | 2023 | 15193 | 0.380 |
Why?
|
| Male | 60 | 2022 | 123000 | 0.370 |
Why?
|
| Infant, Low Birth Weight | 1 | 2010 | 181 | 0.360 |
Why?
|
| Pheochromocytoma | 1 | 2012 | 281 | 0.340 |
Why?
|
| Blood Flow Velocity | 4 | 2005 | 475 | 0.340 |
Why?
|
| Ultrasonography, Prenatal | 4 | 2020 | 830 | 0.330 |
Why?
|
| Hemodynamics | 5 | 2021 | 935 | 0.320 |
Why?
|
| Fetal Heart | 2 | 2020 | 105 | 0.310 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2008 | 112 | 0.310 |
Why?
|
| Observer Variation | 5 | 2021 | 671 | 0.310 |
Why?
|
| Ultrasonography, Interventional | 1 | 2010 | 429 | 0.300 |
Why?
|
| Arrhythmias, Cardiac | 3 | 2023 | 473 | 0.300 |
Why?
|
| Heart Valve Diseases | 2 | 2020 | 193 | 0.300 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2012 | 489 | 0.300 |
Why?
|
| Biomechanical Phenomena | 2 | 2019 | 338 | 0.290 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2023 | 7702 | 0.290 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 4314 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2022 | 7551 | 0.270 |
Why?
|
| Age Factors | 6 | 2021 | 5377 | 0.260 |
Why?
|
| Infant, Premature | 1 | 2010 | 787 | 0.260 |
Why?
|
| Fluorocarbons | 1 | 2005 | 63 | 0.250 |
Why?
|
| Ventricular Remodeling | 1 | 2006 | 248 | 0.240 |
Why?
|
| Aortic Valve | 4 | 2016 | 581 | 0.240 |
Why?
|
| Renal Dialysis | 2 | 2021 | 945 | 0.240 |
Why?
|
| Stents | 1 | 2010 | 1096 | 0.240 |
Why?
|
| Albumins | 1 | 2005 | 258 | 0.240 |
Why?
|
| Mitral Valve | 3 | 2016 | 271 | 0.230 |
Why?
|
| Muscular Dystrophy, Duchenne | 2 | 2016 | 69 | 0.230 |
Why?
|
| Reference Values | 6 | 2021 | 1099 | 0.230 |
Why?
|
| Treatment Outcome | 19 | 2023 | 32848 | 0.230 |
Why?
|
| Heart-Assist Devices | 2 | 2018 | 1171 | 0.220 |
Why?
|
| Longitudinal Studies | 4 | 2022 | 1945 | 0.220 |
Why?
|
| Retrospective Studies | 31 | 2022 | 37905 | 0.220 |
Why?
|
| Heart Septal Defects, Ventricular | 4 | 2020 | 133 | 0.210 |
Why?
|
| Pulmonary Artery | 4 | 2015 | 499 | 0.210 |
Why?
|
| Heart Rate | 4 | 2021 | 737 | 0.210 |
Why?
|
| Adult | 25 | 2023 | 77950 | 0.200 |
Why?
|
| Brain Chemistry | 1 | 2021 | 145 | 0.200 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2014 | 253 | 0.190 |
Why?
|
| Dilatation | 1 | 2020 | 83 | 0.190 |
Why?
|
| Cardiotoxicity | 2 | 2020 | 155 | 0.190 |
Why?
|
| Aorta | 3 | 2011 | 692 | 0.180 |
Why?
|
| Body Height | 1 | 2021 | 231 | 0.180 |
Why?
|
| Risk Factors | 9 | 2020 | 17523 | 0.180 |
Why?
|
| Recovery of Function | 3 | 2012 | 703 | 0.180 |
Why?
|
| Coronary Vessel Anomalies | 4 | 2015 | 300 | 0.180 |
Why?
|
| Pulmonary Valve Stenosis | 2 | 2017 | 44 | 0.180 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2019 | 62 | 0.170 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2020 | 127 | 0.170 |
Why?
|
| Electrocardiography | 7 | 2019 | 1145 | 0.170 |
Why?
|
| Pregnancy | 6 | 2020 | 7573 | 0.170 |
Why?
|
| Cardiovascular Abnormalities | 2 | 2011 | 54 | 0.160 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 14289 | 0.160 |
Why?
|
| Echocardiography, Doppler, Color | 3 | 2010 | 126 | 0.160 |
Why?
|
| Contrast Media | 1 | 2005 | 1472 | 0.160 |
Why?
|
| Hospital Mortality | 2 | 2022 | 1274 | 0.160 |
Why?
|
| Reference Standards | 2 | 2016 | 339 | 0.150 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2017 | 34 | 0.150 |
Why?
|
| Cardiac Surgical Procedures | 3 | 2015 | 1237 | 0.150 |
Why?
|
| Torsion, Mechanical | 1 | 2016 | 8 | 0.150 |
Why?
|
| Follow-Up Studies | 15 | 2020 | 14889 | 0.150 |
Why?
|
| Oxygen | 1 | 2021 | 754 | 0.150 |
Why?
|
| Mitral Valve Stenosis | 2 | 2016 | 50 | 0.140 |
Why?
|
| Time | 1 | 2016 | 178 | 0.140 |
Why?
|
| Gestational Age | 4 | 2016 | 1069 | 0.140 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2005 | 88 | 0.140 |
Why?
|
| Time Factors | 8 | 2020 | 12926 | 0.140 |
Why?
|
| NADP Transhydrogenase, AB-Specific | 1 | 2015 | 4 | 0.130 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 228 | 0.130 |
Why?
|
| Linear Models | 2 | 2016 | 1085 | 0.130 |
Why?
|
| Ultrasonography | 6 | 2014 | 1863 | 0.130 |
Why?
|
| Allografts | 1 | 2017 | 650 | 0.130 |
Why?
|
| Echocardiography, Transesophageal | 5 | 2023 | 303 | 0.130 |
Why?
|
| Critical Care | 1 | 2021 | 770 | 0.130 |
Why?
|
| Heart Conduction System | 1 | 2016 | 165 | 0.130 |
Why?
|
| Registries | 1 | 2022 | 2170 | 0.120 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 220 | 0.120 |
Why?
|
| Case-Control Studies | 4 | 2020 | 6100 | 0.120 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 68 | 0.120 |
Why?
|
| Dilatation, Pathologic | 2 | 2011 | 88 | 0.120 |
Why?
|
| Tetralogy of Fallot | 1 | 1995 | 149 | 0.120 |
Why?
|
| Kidney Failure, Chronic | 1 | 2021 | 960 | 0.110 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2011 | 419 | 0.110 |
Why?
|
| United States Food and Drug Administration | 1 | 2014 | 332 | 0.110 |
Why?
|
| Medical Oncology | 1 | 2021 | 1423 | 0.110 |
Why?
|
| Global Health | 1 | 2017 | 657 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2020 | 1411 | 0.110 |
Why?
|
| Balloon Valvuloplasty | 1 | 2012 | 31 | 0.110 |
Why?
|
| Pilot Projects | 1 | 2019 | 2803 | 0.110 |
Why?
|
| Coffin-Lowry Syndrome | 1 | 2011 | 5 | 0.100 |
Why?
|
| Cardiomyopathy, Restrictive | 1 | 2011 | 20 | 0.100 |
Why?
|
| Radiography, Interventional | 2 | 2011 | 305 | 0.100 |
Why?
|
| GATA4 Transcription Factor | 1 | 2011 | 45 | 0.100 |
Why?
|
| Femoral Vein | 1 | 2011 | 66 | 0.100 |
Why?
|
| Marfan Syndrome | 1 | 2013 | 142 | 0.100 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2006 | 137 | 0.100 |
Why?
|
| Hypertension, Pulmonary | 1 | 2016 | 462 | 0.100 |
Why?
|
| Brazil | 2 | 2021 | 165 | 0.100 |
Why?
|
| Prostheses and Implants | 2 | 2005 | 295 | 0.090 |
Why?
|
| Smith-Magenis Syndrome | 1 | 2011 | 126 | 0.090 |
Why?
|
| Aortic Diseases | 1 | 2013 | 206 | 0.090 |
Why?
|
| Vena Cava, Inferior | 1 | 2011 | 190 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2011 | 317 | 0.090 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 226 | 0.090 |
Why?
|
| HIV Seropositivity | 1 | 2011 | 144 | 0.090 |
Why?
|
| Cardiotonic Agents | 2 | 2004 | 151 | 0.090 |
Why?
|
| Incidence | 2 | 2017 | 5673 | 0.090 |
Why?
|
| Noonan Syndrome | 1 | 2009 | 26 | 0.090 |
Why?
|
| Myocardium | 3 | 2023 | 1313 | 0.090 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2009 | 59 | 0.090 |
Why?
|
| Anti-Retroviral Agents | 1 | 2011 | 148 | 0.090 |
Why?
|
| HIV | 1 | 2011 | 229 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2003 | 5270 | 0.090 |
Why?
|
| Mitochondrial Diseases | 1 | 2011 | 137 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2011 | 160 | 0.090 |
Why?
|
| Severity of Illness Index | 4 | 2014 | 4320 | 0.090 |
Why?
|
| Texas | 6 | 2016 | 6311 | 0.080 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 655 | 0.080 |
Why?
|
| Exercise Test | 2 | 2007 | 312 | 0.080 |
Why?
|
| Antihypertensive Agents | 1 | 2012 | 395 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2020 | 5542 | 0.080 |
Why?
|
| Heterozygote | 1 | 2011 | 1020 | 0.080 |
Why?
|
| Abnormalities, Multiple | 2 | 2011 | 998 | 0.080 |
Why?
|
| Prognosis | 7 | 2014 | 21713 | 0.080 |
Why?
|
| Infant Welfare | 2 | 2004 | 19 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 2195 | 0.080 |
Why?
|
| Databases, Factual | 3 | 2021 | 2218 | 0.080 |
Why?
|
| Sensitivity and Specificity | 3 | 2017 | 4971 | 0.070 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2020 | 62 | 0.070 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 1005 | 0.070 |
Why?
|
| Myofibrils | 1 | 2006 | 31 | 0.070 |
Why?
|
| Acute Disease | 1 | 2012 | 2422 | 0.070 |
Why?
|
| Statistics as Topic | 2 | 2004 | 445 | 0.070 |
Why?
|
| Heart Failure | 2 | 2018 | 2516 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 141 | 0.060 |
Why?
|
| Microspheres | 1 | 2005 | 210 | 0.060 |
Why?
|
| Pediatrics | 2 | 2021 | 1141 | 0.060 |
Why?
|
| Pericardial Effusion | 1 | 2005 | 118 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2005 | 573 | 0.060 |
Why?
|
| Diastole | 2 | 2020 | 187 | 0.060 |
Why?
|
| Aortic Coarctation | 3 | 2016 | 103 | 0.060 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 102 | 0.060 |
Why?
|
| Trisomy | 1 | 2005 | 231 | 0.060 |
Why?
|
| Diagnostic Imaging | 2 | 2023 | 1162 | 0.060 |
Why?
|
| Transposition of Great Vessels | 2 | 2004 | 124 | 0.060 |
Why?
|
| Vectorcardiography | 1 | 2003 | 4 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2005 | 216 | 0.060 |
Why?
|
| Mitochondrial Myopathies | 1 | 2003 | 28 | 0.060 |
Why?
|
| Child Welfare | 1 | 2004 | 66 | 0.060 |
Why?
|
| Tricuspid Valve | 1 | 2004 | 68 | 0.060 |
Why?
|
| Family | 2 | 2005 | 736 | 0.060 |
Why?
|
| Remission, Spontaneous | 1 | 2003 | 119 | 0.060 |
Why?
|
| Acyltransferases | 1 | 2003 | 62 | 0.060 |
Why?
|
| Survival Rate | 4 | 2018 | 12221 | 0.060 |
Why?
|
| Myocardial Reperfusion | 1 | 2003 | 108 | 0.060 |
Why?
|
| Catheterization | 1 | 2005 | 410 | 0.060 |
Why?
|
| Sinus of Valsalva | 1 | 2003 | 53 | 0.050 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2004 | 167 | 0.050 |
Why?
|
| Milrinone | 1 | 2022 | 33 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2015 | 6207 | 0.050 |
Why?
|
| Aortic Rupture | 1 | 2003 | 113 | 0.050 |
Why?
|
| Cohort Studies | 4 | 2019 | 9244 | 0.050 |
Why?
|
| Hypoxia, Brain | 1 | 2021 | 31 | 0.050 |
Why?
|
| Endocarditis, Bacterial | 1 | 2003 | 128 | 0.050 |
Why?
|
| Fetal Diseases | 1 | 2005 | 388 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 5539 | 0.050 |
Why?
|
| Facies | 2 | 2011 | 149 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2007 | 686 | 0.050 |
Why?
|
| Blood Volume | 1 | 2021 | 100 | 0.050 |
Why?
|
| Middle Aged | 8 | 2022 | 86204 | 0.050 |
Why?
|
| Stress, Mechanical | 2 | 2016 | 311 | 0.050 |
Why?
|
| Boston | 1 | 2020 | 108 | 0.050 |
Why?
|
| Anti-HIV Agents | 1 | 2004 | 350 | 0.050 |
Why?
|
| Oximetry | 1 | 2021 | 172 | 0.050 |
Why?
|
| Family Health | 2 | 2015 | 325 | 0.040 |
Why?
|
| Wisconsin | 1 | 2019 | 27 | 0.040 |
Why?
|
| Multimodal Imaging | 1 | 2023 | 550 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2013 | 1323 | 0.040 |
Why?
|
| Young Adult | 5 | 2018 | 21445 | 0.040 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2006 | 705 | 0.040 |
Why?
|
| Hospitals, Pediatric | 2 | 2015 | 773 | 0.040 |
Why?
|
| ROC Curve | 2 | 2016 | 1183 | 0.040 |
Why?
|
| American Heart Association | 1 | 2020 | 310 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2007 | 1429 | 0.040 |
Why?
|
| Ireland | 1 | 2018 | 30 | 0.040 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1999 | 160 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 471 | 0.040 |
Why?
|
| Fetus | 1 | 2021 | 601 | 0.040 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2006 | 1303 | 0.040 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2011 | 2796 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2020 | 597 | 0.040 |
Why?
|
| Transplant Recipients | 1 | 2020 | 324 | 0.040 |
Why?
|
| Sample Size | 1 | 2017 | 202 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2017 | 187 | 0.040 |
Why?
|
| United States | 4 | 2023 | 15433 | 0.040 |
Why?
|
| Dobutamine | 1 | 1997 | 54 | 0.040 |
Why?
|
| North America | 1 | 2017 | 314 | 0.040 |
Why?
|
| Reoperation | 2 | 2016 | 1382 | 0.040 |
Why?
|
| Georgia | 1 | 2016 | 53 | 0.040 |
Why?
|
| Tensile Strength | 1 | 2016 | 73 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 2403 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2016 | 37 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 1996 | 135 | 0.030 |
Why?
|
| Mutation | 3 | 2011 | 15179 | 0.030 |
Why?
|
| Pediatric Obesity | 1 | 2021 | 364 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1996 | 1471 | 0.030 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2011 | 317 | 0.030 |
Why?
|
| Equipment Design | 2 | 2012 | 1204 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2011 | 234 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2015 | 125 | 0.030 |
Why?
|
| Recurrence | 1 | 2003 | 4758 | 0.030 |
Why?
|
| Proteins | 1 | 2003 | 1963 | 0.030 |
Why?
|
| Nomograms | 1 | 2017 | 313 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2013 | 2307 | 0.030 |
Why?
|
| Hospitalization | 1 | 2004 | 2083 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 2015 | 73 | 0.030 |
Why?
|
| Catheter Ablation | 1 | 2000 | 620 | 0.030 |
Why?
|
| Fistula | 1 | 1995 | 76 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2020 | 795 | 0.030 |
Why?
|
| Pedigree | 2 | 2015 | 1890 | 0.030 |
Why?
|
| Embryo, Nonmammalian | 1 | 2015 | 234 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2015 | 289 | 0.030 |
Why?
|
| Models, Cardiovascular | 1 | 1995 | 202 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 1999 | 551 | 0.030 |
Why?
|
| Aorta, Thoracic | 1 | 1999 | 546 | 0.030 |
Why?
|
| Polytetrafluoroethylene | 1 | 2014 | 113 | 0.030 |
Why?
|
| Proportional Hazards Models | 2 | 2013 | 4988 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 406 | 0.030 |
Why?
|
| Software | 1 | 2021 | 1321 | 0.030 |
Why?
|
| Adrenergic beta-1 Receptor Antagonists | 1 | 2013 | 17 | 0.030 |
Why?
|
| Siblings | 2 | 2005 | 285 | 0.030 |
Why?
|
| Atenolol | 1 | 2013 | 42 | 0.030 |
Why?
|
| Atrial Flutter | 1 | 2013 | 21 | 0.030 |
Why?
|
| Losartan | 1 | 2013 | 46 | 0.030 |
Why?
|
| Tachycardia | 1 | 2013 | 70 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 1351 | 0.030 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 369 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 663 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2020 | 1824 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2013 | 68 | 0.030 |
Why?
|
| Miniaturization | 1 | 2012 | 47 | 0.030 |
Why?
|
| Shock, Septic | 1 | 1994 | 181 | 0.030 |
Why?
|
| Zebrafish | 1 | 2015 | 463 | 0.030 |
Why?
|
| Disease Progression | 1 | 2003 | 6682 | 0.030 |
Why?
|
| Sex Factors | 1 | 2017 | 2139 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2015 | 598 | 0.030 |
Why?
|
| Cineangiography | 2 | 2005 | 22 | 0.030 |
Why?
|
| Dextrocardia | 1 | 2011 | 10 | 0.030 |
Why?
|
| Dystrophin | 1 | 2011 | 41 | 0.030 |
Why?
|
| Gene Order | 1 | 2011 | 111 | 0.030 |
Why?
|
| Angiography | 2 | 2006 | 360 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2014 | 749 | 0.030 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2018 | 581 | 0.020 |
Why?
|
| Comorbidity | 1 | 2018 | 2352 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2011 | 88 | 0.020 |
Why?
|
| HIV Infections | 1 | 2004 | 2134 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 403 | 0.020 |
Why?
|
| Heterotaxy Syndrome | 1 | 2011 | 63 | 0.020 |
Why?
|
| Postoperative Care | 1 | 2015 | 739 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2015 | 6869 | 0.020 |
Why?
|
| Chromosome Duplication | 1 | 2011 | 157 | 0.020 |
Why?
|
| Zinc Fingers | 1 | 2011 | 205 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2007 | 2292 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1997 | 1648 | 0.020 |
Why?
|
| Exome | 1 | 2015 | 1239 | 0.020 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2011 | 691 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 2011 | 417 | 0.020 |
Why?
|
| Preoperative Care | 1 | 2015 | 1529 | 0.020 |
Why?
|
| Belgium | 1 | 2008 | 47 | 0.020 |
Why?
|
| Heart Septum | 1 | 2008 | 54 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 5687 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2015 | 2483 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 1582 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 2013 | 899 | 0.020 |
Why?
|
| Lod Score | 2 | 1996 | 157 | 0.020 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2012 | 563 | 0.020 |
Why?
|
| Logistic Models | 1 | 2013 | 3441 | 0.020 |
Why?
|
| Hydrops Fetalis | 1 | 2005 | 66 | 0.020 |
Why?
|
| Elasticity | 1 | 2005 | 156 | 0.020 |
Why?
|
| Fetal Death | 1 | 2005 | 113 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2005 | 110 | 0.020 |
Why?
|
| Double Outlet Right Ventricle | 1 | 2004 | 17 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 9180 | 0.020 |
Why?
|
| Genetic Linkage | 2 | 1996 | 512 | 0.020 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 2004 | 239 | 0.020 |
Why?
|
| Multifactorial Inheritance | 1 | 2005 | 148 | 0.020 |
Why?
|
| Phenotype | 2 | 2011 | 6295 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2004 | 66 | 0.020 |
Why?
|
| HIV Seronegativity | 1 | 2004 | 32 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2005 | 495 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2007 | 1546 | 0.010 |
Why?
|
| Age Distribution | 1 | 2005 | 698 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2004 | 460 | 0.010 |
Why?
|
| Exercise Tolerance | 1 | 2004 | 107 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 409 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2004 | 231 | 0.010 |
Why?
|
| Chest Pain | 1 | 2004 | 155 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2004 | 371 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2004 | 401 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 2004 | 239 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 1972 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2004 | 358 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 4938 | 0.010 |
Why?
|
| Prosthesis Implantation | 1 | 2001 | 263 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2005 | 1960 | 0.010 |
Why?
|
| Parents | 1 | 2004 | 998 | 0.010 |
Why?
|
| Aged | 4 | 2005 | 70117 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 4744 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 1996 | 246 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 418 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1995 | 290 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 1995 | 327 | 0.010 |
Why?
|
| Aortic Aneurysm | 1 | 1995 | 230 | 0.010 |
Why?
|
| Resuscitation | 1 | 1994 | 223 | 0.010 |
Why?
|
| Biomarkers | 1 | 2004 | 5047 | 0.010 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 1994 | 441 | 0.010 |
Why?
|
| Animals | 1 | 2015 | 59536 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1994 | 1467 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2005 | 29902 | 0.000 |
Why?
|